2022
Clinical Outcomes of Revascularization with Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Replacement: A Comprehensive Meta-Analysis
Altibi A, Ghanem F, Hammad F, Patel J, Song H, Golwala H, Zahr F, Rahmouni H. Clinical Outcomes of Revascularization with Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Replacement: A Comprehensive Meta-Analysis. Current Problems In Cardiology 2022, 47: 101339. PMID: 35908687, DOI: 10.1016/j.cpcardiol.2022.101339.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve replacementCoexisting coronary artery diseaseIncreased risk of life-threatening bleedingCoronary artery diseaseRisk of life-threatening bleedingLife-threatening bleedingAortic valve replacementOutcomes of revascularizationValve replacementIncreased riskOdds ratioTranscatheter aortic valve replacement patientsSignificant coronary artery diseasePooled estimates of odds ratiosMeta-analysisAcute kidney injuryEstimates of odds ratiosAssociated with improved 30-dayPercutaneous coronary interventionRandom-effects modelNo significant differencePacemaker implantationPost-TAVRKidney injuryClinical outcomes
2020
Assessment of right ventricular function following left ventricular assist device (LVAD) implantation—The role of speckle‐tracking echocardiography: A meta‐analysis
Barssoum K, Altibi A, Rai D, Kharsa A, Kumar A, Chowdhury M, Elkaryoni A, Abuzaid A, Baibhav B, Parikh V, Masri A, Amsallem M, Nanda N. Assessment of right ventricular function following left ventricular assist device (LVAD) implantation—The role of speckle‐tracking echocardiography: A meta‐analysis. Echocardiography 2020, 37: 2048-2060. PMID: 33084128, DOI: 10.1111/echo.14884.Peer-Reviewed Original ResearchConceptsRight ventricle free wall strainRight ventricle global longitudinal strainRight ventricular failureSpeckle-tracking echocardiographyRight ventricular failure patientsLeft ventricular assist deviceStandardized mean differenceTransthoracic echocardiographyPrediction of right ventricular failureSubgroup analysisAssessment of right ventricular functionVentricular assist deviceOdds ratioAssociated with worse outcomesFree wall strainGlobal longitudinal strainRight ventricular functionLeft ventricular assist device recipientsMeta-analysisMeta-analysis of published literaturePooled odds ratioRandom-effects modelNo significant differenceVentricular failureVentricular functionSpeckle tracking echocardiography can predict subclinical myocardial involvement in patients with sarcoidosis: A meta‐analysis
Barssoum K, Altibi A, Rai D, Kumar A, Kharsa A, Chowdhury M, Thakkar S, Shahid S, Abdelazeem M, Abuzaid A, Baibhav B, Parikh V, Feitell S, Balmer‐Swain M, Rao M, Amsallem M, Nanda N. Speckle tracking echocardiography can predict subclinical myocardial involvement in patients with sarcoidosis: A meta‐analysis. Echocardiography 2020, 37: 2061-2070. PMID: 33058271, DOI: 10.1111/echo.14886.Peer-Reviewed Original ResearchConceptsLeft ventricular global longitudinal strainGlobal circumferential strainSpeckle tracking echocardiographyStandardized mean differenceCardiac sarcoidosisCardiac magnetic resonanceSarcoidosis groupTracking echocardiographyHealthy controlsConfidence intervalsExtra-cardiac sarcoidosisGlobal longitudinal strainSubclinical myocardial involvementMeta-analysisScreening of CSAdvanced imaging modalitiesRandom-effects modelEnglish-language articlesPositron emission tomographyMyocardial involvementSarcoidosis patientsCardiac symptomsFDG-PETLongitudinal strainEchocardiography
2018
Clinicopathological implications of MET exon 14 mutations in non-small cell lung cancer – A systematic review and meta-analysis
Vuong H, Ho A, Altibi A, Nakazawa T, Katoh R, Kondo T. Clinicopathological implications of MET exon 14 mutations in non-small cell lung cancer – A systematic review and meta-analysis. Lung Cancer 2018, 123: 76-82. PMID: 30089599, DOI: 10.1016/j.lungcan.2018.07.006.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerMET exonCell lung cancerAdvanced non-small cell lung cancerLung cancerGenetic eventsOdds ratioPulmonary sarcomatoid carcinomaMeta-analysisConfidence intervalsC-Met inhibitorsRandom-effects modelSarcomatoid carcinomaPrognostic featuresClinicopathological profileDismal survivalTargeted therapyClinicopathological implicationsGenomic alterationsAdvanced ageWeb of ScienceC-MetNon-smokersRare mutationsPatients
2017
Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations—a meta-analysis
Vuong H, Altibi A, Duong U, Ngo H, Pham T, Tran H, Oishi N, Mochizuki K, Nakazawa T, Hassell L, Katoh R, Kondo T. Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations—a meta-analysis. Tumor Biology 2017, 39: 1010428317713913. PMID: 29037127, DOI: 10.1177/1010428317713913.Peer-Reviewed Original ResearchConceptsPapillary thyroid cancerTERT promoter mutationsDistant metastasisThyroid cancerPromoter mutationsRET/PTC rearrangementsBRAF mutationsPresence of distant metastasesAssessment of patient prognosisTumor risk stratificationAssociated with distant metastasisPapillary thyroid carcinomaMeta-analysisPredicting distant metastasisAssociation of BRAFRandom-effects modelThyroid carcinomaTERT promoterRisk stratificationPatient prognosisRAS mutationsAdverse outcomesMetastasisIncreased riskBRAFTERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups—A meta-analysis of aggregate data
Vuong H, Altibi A, Duong U, Ngo H, Pham T, Chan A, Park C, Fung K, Hassell L. TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups—A meta-analysis of aggregate data. Critical Reviews In Oncology/Hematology 2017, 120: 1-9. PMID: 29198322, DOI: 10.1016/j.critrevonc.2017.09.013.Peer-Reviewed Original ResearchConceptsTelomerase reverse transcriptase promoter mutationTelomerase reverse transcriptaseIsocitrate dehydrogenase mutation statusProgression-free survivalTERT promoter mutationsIsocitrate dehydrogenase mutationPromoter mutationsIDH-mutantGlioma patientsOverall survivalTumor gradeMutation statusTelomerase reverse transcriptase mutationsAssociated with reduced OSGrade II/III tumorsWHO grade IIMeta-analysisIDH-wild typeInverse variance methodRandom-effects modelII/III tumorsTERT-mutIII tumorsPrognostic factorsPrognostic valuePrognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma—A meta‐analysis
Vuong H, Altibi A, Duong U, Hassell L. Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma—A meta‐analysis. Clinical Endocrinology 2017, 87: 411-417. PMID: 28666074, DOI: 10.1111/cen.13413.Peer-Reviewed Original ResearchConceptsTERT promoter mutationsPapillary thyroid carcinomaPromoter mutationsRisk stratificationRisk stratification of papillary thyroid carcinomaAssociated with increased tumor aggressivenessManagement of papillary thyroid carcinomaGroup of papillary thyroid carcinomasPapillary thyroid carcinoma patientsPooled estimates of odds ratiosCombination of BRAFEstimates of odds ratiosRandom-effects modelCoexisting BRAFThyroid carcinomaPrognostic implicationsTumor aggressivenessClinicopathological implicationsBRAFClinical managementConcurrent BRAFRisk groupsOdds ratioVirtual Health LibraryWeb of ScienceBRAF Mutation is Associated with an Improved Survival in Glioma—a Systematic Review and Meta-analysis
Vuong H, Altibi A, Duong U, Ngo H, Pham T, Fung K, Hassell L. BRAF Mutation is Associated with an Improved Survival in Glioma—a Systematic Review and Meta-analysis. Molecular Neurobiology 2017, 55: 3718-3724. PMID: 28534272, DOI: 10.1007/s12035-017-0599-y.Peer-Reviewed Original ResearchConceptsProgression-free survivalKaplan Meier curveOverall survivalBRAF V600EPrognostic valueBRAF mutationsGlioma patientsImproved survivalData of hazard ratioHazard ratioYoung adult gliomasImproved overall survivalMeta-analysisInverse variance methodLow grade gliomasVirtual Health LibraryPrognosis of glioma patientsRandom-effects modelPrognostic impactPrognostic factorsTumor gradeFavorable prognosisPatient ageAdult gliomasPooled HRA meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma
Vuong H, Duong U, Altibi A, Ngo H, Pham T, Tran H, Gandolfi G, Hassell L. A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma. Endocrine Connections 2017, 6: r8-r17. PMID: 28219937, PMCID: PMC5424840, DOI: 10.1530/ec-17-0010.Peer-Reviewed Original ResearchDisease-specific survivalDisease-free survivalPapillary thyroid carcinomaKaplan-Meier curvesPromoter mutationsHazard ratioPrognostic roleThyroid carcinomaData of hazard ratioVirtual Health LibraryAssess patient prognosisPooled hazard ratioInverse variance methodConfidence intervalsPrognosis of PTC patientsPredicting patient outcomesVisual inspection of funnel plotsMeta-analysesInspection of funnel plotsRandom-effects modelPrognostic valuePTC patientsEgger's regression testRisk stratificationPatient prognosis